Spots Global Cancer Trial Database for salivary gland tumors
Every month we try and update this database with for salivary gland tumors cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors | NCT02921984 | Salivary Gland ... Head and Neck C... | Docetaxel Intensity-modul... Pemetrexed Cisplatin | 18 Years - 70 Years | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | |
| Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms | NCT05000892 | Salivary Gland ... Salivary Gland ... | Sintilimab , Ca... | 18 Years - 80 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms | NCT05000892 | Salivary Gland ... Salivary Gland ... | Sintilimab , Ca... | 18 Years - 80 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Phase II Study of RC48-ADC in Treating Patients With Salivary Gland Tumors Expressing HER2 | NCT05601401 | Salivary Gland ... | RC48-ADC | 18 Years - | Peking Union Medical College Hospital | |
| Neoadjuvant Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms | NCT04825938 | Salivary Gland ... Salivary Gland ... | Toripalimab , C... | 18 Years - 80 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors | NCT02776163 | Salivary Gland ... Head and Neck C... | Cisplatin Docetaxel Intensity-modul... | 18 Years - 70 Years | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | |
| Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors | NCT02921984 | Salivary Gland ... Head and Neck C... | Docetaxel Intensity-modul... Pemetrexed Cisplatin | 18 Years - 70 Years | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | |
| Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy | NCT01586767 | Adenoid Cystic ... Squamous Cell C... Sinonasal Carci... Sinonasal Undif... Mucoepidermoid ... Schneiderian Ca... Myoepithelial C... Esthesioneurobl... Melanoma | Proton radiatio... Intensity-modul... | 18 Years - | Massachusetts General Hospital | |
| Phase II Study of RC48-ADC in Treating Patients With Salivary Gland Tumors Expressing HER2 | NCT05601401 | Salivary Gland ... | RC48-ADC | 18 Years - | Peking Union Medical College Hospital | |
| Neoadjuvant Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms | NCT04825938 | Salivary Gland ... Salivary Gland ... | Toripalimab , C... | 18 Years - 80 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Neoadjuvant Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms | NCT04825938 | Salivary Gland ... Salivary Gland ... | Toripalimab , C... | 18 Years - 80 Years | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | |
| Phase II Study of RC48-ADC in Treating Patients With Salivary Gland Tumors Expressing HER2 | NCT05601401 | Salivary Gland ... | RC48-ADC | 18 Years - | Peking Union Medical College Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
